Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

DOI Full Paper Access

608

Citations

21

References

2021

Year

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, Duncan R. McKenzie, Irene del Molino del Barrio, Thanussuyah Alaguthurai, Clara Domingo‐Vila, Thomas S. Hayday, Carl Graham, Jeffrey Seow,

The Lancet Oncology

References

	Year	Citations

Page 1